Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial - Gambacorti-Passerini, C.; Brümmendorf, T.H.; Abruzzese, E.; Kelly, K.R.; Oehler, V.G.; García-Gutiérrez, V.; Hjorth-Hansen, H.; Ernst, T.; Leip, E.; Purcell, S.; Luscan, G.; Viqueira, A.; et al. (Leukemia, 2024)